Device Innovation Consortium Plans To Finish Patient-Centered Project This Year
This article was originally published in The Gray Sheet
Executive Summary
The public-private partnership created to advance medical device regulatory science is starting 2014 with a renewed focus on its three projects and plans to possibly add a fourth to the mix.
You may also be interested in...
FDA Steps Up Focus On Computational Modeling For Devices With Draft Guidance
The draft guidance outlines information on computational and simulation modeling studies that should be included in FDA device submissions. FDA has been encouraging companies to focus on modeling studies with a goal that they could eventually replace costly bench and animal studies.
Medical Device Innovation Consortium Advances Regulatory Science Projects
At the Regulatory Affairs Professionals Society annual meeting last week, William Hawkins, chairman of the Medical Device Innovation Consortium, said the group is making progress in its first project on computer modeling and simulation, as well as future projects on clinical trial reform, and benefit-risk guidance and patient-centeredness.
FDA Validates Tool For Incorporating Patient Preferences In Regulatory Decisions
A pilot study that explored how much risk patients would be willing to tolerate from a device implant in order to achieve significant weight loss is helping CDRH regulators understand how to accurately and reliably measure patient preferences. The goal is to start incorporating those preferences into regulatory decisions for certain devices, officials explained at a Sept. 18-19 workshop.